Title 69 — Title 69 FOOD, DRUGS, COSMETICS, AND POISONS
31 chapters · 620 sections in this title.
RCW 69.78.010 Finding—Policy.
2.2K chars
(1) The legislature finds that controlled clinical trials provide a critical base of evidence for evaluating whether a medical product is safe and effective before the product is approved for marketing. The United States food and drug administration has evaluated demographic prof…
RCW 69.78.020 Definitions.
0.8K chars
The definitions in this section apply throughout this chapter unless the context clearly requires otherwise.(1) "Washington state review board" or "review board" means the Washington state institutional review board, established pursuant to 45 C.F.R. Part 46, which is the designa…
RCW 69.78.030 Diversity in clinical trials program.
1.5K chars
The Washington state review board shall establish a diversity in clinical trials program to encourage participation in clinical trials of drugs and medical devices by persons who are members of demographic groups that are underrepresented in clinical trials. In developing this pr…
RCW 69.78.040 Requirements for state entities or hospitals conducting clinical trials.
1.0K chars
Any state entity or hospital that receives funding from the national institutes of health to conduct clinical trials of drugs or medical devices shall:(1) Adopt a policy concerning the identification and recruitment of persons who are members of underrepresented demographic group…